Search

everythinglearnresearchcommunity

for

Search:↓

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

Some people lose a lot of hair after having COVID-19.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

COVID-19 and its vaccines can cause various skin issues, with urticaria being the most common.

COVID-19 can cause temporary hair loss.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Rosella C. believes an earlier diagnosis of Cushing disease could have prevented severe symptoms.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

The COVID-19 pandemic led to more young people getting red stretch marks due to lifestyle changes like less activity and quick weight gain.

COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

COVID-19 reduced dermatology visits by 30.4%, with more male patients and increased cases of psoriasis, bullous diseases, and melanoma.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Social media data can help track and predict COVID-19 symptoms and trends.

The pandemic changed how often certain skin conditions were diagnosed.

People who had severe COVID-19 are more likely to experience hair loss.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

AI is revolutionizing healthcare by improving diagnosis, treatment, and monitoring, but still needs close supervision.